GG 614 GG 614 (RANITIDINE 150 mg)

Pill imprint GG 614 GG 614 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GG 614 GG 614

Ranitidine hydrochloride 150 mg GG 614 GG 614 Front
Ranitidine hydrochloride 150 mg GG 614 GG 614 Back
Ranitidine hydrochloride
Imprint:
GG 614
GG 614
Strength:
150 mg
Color:
Brown
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-2855
Inactive Ingredients:
ammonia
corn starch
FD&C Blue No. 1
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
magnesium stearate
propylene glycol
silicon dioxide
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0337 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)